As vessels try to ensure safe passage through the Strait of Hormuz this week, one bulk carrier signaled it was Chinese-owned as it transited. The Iron Maiden changed its destination signal to 'CHINA OWNER,' according to ship-tracking data.
Peking University Professor and PBOC adviser Huang Yiping discusses China's shift toward sustainable growth following Premier Li Qiang's latest address to lawmakers. Speaking exclusively with Bloomberg TV, he analyzes the need for quality growth while maintaining control over fiscal spending.
Goldman Sachs Natural Gas Research Head Samantha Dart says a scenario where Brent crude prices cross the 100 dollar threshold as "possible" if the Strait of Hormuz were to experience several weeks of interrupted oil flow.
Diana Shipping escalated its pursuit of Genco Shipping & Trading on Friday, raising its all-cash offer to $23.50 per share in a sweetened bid backed by a $1.43 billion financing package and a strategic vessel-sale agreement with Star Bulk Carriers.
Imperial Petroleum reported a surge in fourth-quarter revenue and sustained annual profitability, as the Athens-based shipowner leverages a debt-free balance sheet to aggressively expand its presence in the tanker and drybulk markets.
Tsakos Energy Navigation (NYSE:TEN) posted a sharp rise in full-year profitability for 2025, as the Greek tanker major capitalized on high fleet utilization and a strategic push into the LNG and specialized vessel markets.
SunCar Technology Group (NASDAQ:SDA) issued a bullish outlook for the coming fiscal year, forecasting a 20% jump in revenue as the digital auto platform leverages artificial intelligence and deepening electric vehicle (EV) partnerships to drive profitability.
Halozyme Therapeutics (NASDAQ:HALO) shares were in focus Friday after partner Johnson & Johnson secured U.S. regulatory approval for a subcutaneous combination therapy that significantly reduces the risk of disease progression in patients with relapsed multiple myeloma.
Hurco Companies (NASDAQ:HURC) reported a reduced net loss for the first quarter of fiscal 2026, finding a silver lining in a double-digit surge in domestic orders despite a dip in global sales.
PMV Pharmaceuticals (NASDAQ:PMVP) reported significant clinical momentum for its lead candidate, rezatapopt, bolstered by a fresh FDA Orphan Drug Designation and clinical results showing high response rates in late-stage ovarian cancer patients.
Cohen & Company (NYSE:COHN) capped a transformative fiscal year with a massive top-line expansion, fueled by a 246% year-over-year revenue increase that prompted the board to reward shareholders with both a quarterly and a special dividend.
Mammoth Energy Services (NASDAQ:TUSK) capped off a year of aggressive restructuring, reporting full-year 2025 results that highlight a dramatic shift from traditional oilfield services toward a specialized aviation and rental platform.
_1354895_640x360_2490875971553-640x360.jpg&w=3840&q=75)
